About Us
Overview
A leading incubator for cancer treatment innovations with a focus on the diagnosis and treatment of multiple myeloma, other B-cell malignancies and related disorders.
- ONCOtracker, Inc. is a West Hollywood-based oncology company pursuing intellectual property for innovative treatments leading to dramatically improved outcomes.
- We have exclusive rights to a Serum B-Cell Maturation Antigen (sBCMA) blood test, which is being developed to monitor tumor burden and predict the therapeutic outcome of multiple myeloma patients.
- sBCMA is being investigated for clinical application in chronic lymphocytic leukemia, B-cell lymphoma and select solid tumor malignancies.
- ONCOtracker has intellectual property related to novel treatment approaches for multiple myeloma, which are being pursued in ongoing clinical trials.
Leadership
![james-berenson](https://i0.wp.com/oncotracker.com/wp-content/uploads/2023/07/james-berenson-new-light.jpg?resize=300%2C300&ssl=1)
James R. Berenson, MD
Founder
and Principal
![Jessica Yataco](https://i0.wp.com/oncotracker.com/wp-content/uploads/2021/08/jessicca-300x300-1.jpg?resize=300%2C300&ssl=1)
Jessica Yataco
Chief Operating Officer
Scientific Advisory Committee
![](https://i0.wp.com/oncotracker.com/wp-content/uploads/2020/06/Ola-Landgren.jpg?resize=300%2C300&ssl=1)
O. Landgren, MD, PhD
Scientific Advisory
Committee Member
![](https://i0.wp.com/oncotracker.com/wp-content/uploads/2020/06/Dr.-Suzanne-Lentzsch.jpg?resize=300%2C300&ssl=1)
S. Lentzsch, MD, PhD
Scientific Advisory
Committee Member
![](https://i0.wp.com/oncotracker.com/wp-content/uploads/2020/06/Rafael-Fonseca.jpg?resize=300%2C300&ssl=1)
R. Fonseca, MD, PhD
Scientific Advisory
Committee Member
![](https://i0.wp.com/oncotracker.com/wp-content/uploads/2020/06/Maher-Albitar.jpg?resize=300%2C300&ssl=1)
M. Albitar, MD, PhD
Scientific Advisory
Committee Member